Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve (i) the Standalone and Consolidated ....
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has informed the stock exchanges that its Board of Directors will meet on Thursday, 29th May, 2025. The main items on the agenda are: (1) approval of the Standalone and Consolidated Audited Financial Results for the quarter and full financial year ended 31st March, 2025, and (2) consideration and recommendation of a Final Dividend, if any, for FY25. This is a standard pre-results intimation filed under SEBI Listing Regulations. The actual numbers, dividend amount, and any other announcements will only be known after the board meeting.
This filing itself is purely procedural and is not expected to move the stock. Investors should watch the 29th May meeting for the actual Q4 results, full-year numbers, and any final dividend announcement, which could be price-sensitive.